Vascarta's transdermal curcumin gel formulation ("VAS-101") experienced reduced pain and inflammation along with improved red blood cell stability and functionality. Based in part on these favorable ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

For the average person, living at high altitude-where oxygen is sparser than at sea level-can have health benefits ranging ...

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

Scientists at Gladstone Institutes have developed a drug that mimics the effects of breathing low oxygen. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the HypoxyStat ...

Drug-based therapy, starting with hydroxyurea ... The World Coalition on Sickle Cell Disease, launched in 2023, is an excellent example of the type of collaboration that will be needed to expand ...

As treatment and care continues to evolve, we must ensure that people living with this disease are able to advocate for ...

People living with sickle cell are apprehensive about a revolutionary new one-off treatment that has just been approved for use on the NHS. | ITV News Granada ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.